We are pleased to invite you to our Virtual User and Applications Meeting. In these 3 sessions you will be hearing the latest news and developments from the experts in Proteomics, Metabolomics/Lipidomics and Imaging.
09:30 - 10:00 Intro and Proteomics Update
Torsten Müller, Ph.D., Business Development Manager - Proteomics (DACH), Bruker Daltonics, Germany
10:00 - 10:30 timsTOF Prosit improves the identification of non-tryptic peptides
Matthias Wilhelm, Ph.D., Professor, Computational Mass Spectrometry, Technical University Munich, Germany
10:30 - 11:00 A region-resolved proteomic map of the human brain enabled by high-throughput proteomics
Johanna Tueshaus, Ph.D., Postdoctoral researcher, Technical University Munich, Germany
11:00 - 11:10 Break
11:10 - 11:40 timsTOF mass spectrometry-based immunopeptidomics identification refines tumor antigen identification
Naomi Hönisch Gravel, Ph.D. Student, Peptide-based Immunotherapy, AG J. Walz, University and University Hospital Tübingen, Germany
11:40 - 12:10 µPhos: A scalable and sensitive platform for functional phosphoproteomics
Florian Meier, Ph.D., Junior Professor, Functional Proteome Analysis, Jena University Hospital, Germany
12:10 - 12:30 Meet the Experts
Lisa Abel, Field Application Scientist, Bruker Daltonics, Germany
Raphael Schuster, Ph.D., Field Application Scientist, Bruker Daltonics, Germany
Tobias Kroniger, Field Application Scientist, Bruker Daltonics, Germany
09:30 - 10:00 Intro and Metabolomics/Lipidomics Update
Stefanie Wernisch, Ph.D., Business Development Manager Metabolomics/, Bruker Daltonics, Germany
10:00 - 10:30 Distinguishing ether-linked phospholipids by ion mobility coupled to mass spectrometry
Markus Keller, Ph.D., Principal Investigator, Medical University of Innsbruck, Institute of Human Genetics, Austria
10:30 - 11:00 Spatial metabolomics toward investigation of tissue heterogeneity and microenvironment
Laimdota Zizmare, Ph.D., Postdoctoral Researcher, The M3 Research Center for Microbiome, Metabolome and Malignancy, WSIC, University Hospital Tübingen, Germany
11:00 - 11:10 Break
11:10 - 11:40 SuperM – combining targeted and untargeted metabolomics into a single platform for target discovery and validation at scale
Marco Hennrich, Ph.D., Investigator, Cellzome GSK Heidelberg, Germany
11:40 - 12:10 Advancing lipidome’s quantitative coverage in pre-clinical and clinical samples with targeted and untargeted 4D- tims platforms
Laura Bindila, Ph.D., Head of Clinical Lipidomics Unit, University Medical Center Mainz, Institute of Physiological Chemistry, Germany
12:10 - 12:30 Meet the Experts
Viola Jeck, Ph.D., Application Scientist Metabolomics, Bruker Daltonics, Germany
Nikolas Kessler, Ph.D., Head of Metabolomics Software R&D, Bruker Daltonics, Germany
Sven Meyer, Ph.D., Applications Development Scientist, Bruker Daltonics, Germany
09:30 - 10:00 Intro and MALDI Imaging Update
Björn Wendik, Ph.D., Business Development Manager MALDI Imaging, Bruker Daltonics, Germany
10:00 - 10:30 Multimodal chemical imaging using spectroscopy and mass spectrometry
Uwe Karst, Ph.D., Chair of Analytical Chemistry, University of Münster, Institute of Inorganic and Analytical Chemistry, Germany
10:30 - 11:00 Simultaneous detection of over hundreds protein markers by MALDI-IHC: what have we learned so far
Mengze Zhang, Ph.D. student, University of Zurich, Department of Quantitative Biomedicine, Bodenmiller lab, Switzerland
11:00 - 11:10 Break
11:10 - 11:40 MALDI MSI – Applications in Pathology
Kristina Schwamborn, Ph.D., Head of Mass Spectrometry Imaging (MSI) lab, Technical University Munich, Institute of Pathology, Germany
11:40 - 12:10 MALDI Imaging based spatial multi-omics for uncovering novel biomedical perspectives in rare cancers
Melanie Föll, Ph.D., Junior research group, University Medical Center Freiburg, Institute of Surgical Pathology, Germany
12:10 - 12:30 Meet the Experts
Andras Kiss, Ph.D., Field Application Support Engineer, Bruker Austria, Austria
Corinna Henkel, Ph.D., Application Specialist MALDI Imaging, Bruker Daltonics, Germany
For Research Use Only. Not for use in clinical diagnostic procedures.